Paper7007597
The pathogenesis and treatment of pulmonary infections in patients with cystic fibrosis.
Marks MI. J Pediatr, 1981. Cited by 157 papers, by iCite.
Cite this record
ConductScience Library. The pathogenesis and treatment of pulmonary infections in patients with cystic fibrosis. Papers, record 7007597. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7007597
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cystic Fibrosis | Major topic |
| Respiratory Tract Infections | Major topic |
| Animals | |
| Anti-Bacterial Agents | |
| Child | |
| Humans | |
| Immunologic Techniques | |
| Pneumonia | |
| Pseudomonas Infections | |
| Rabbits | |
| Rats | |
| Sputum | |
| Staphylococcal Infections |
Source PubMed
Cited by32
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 157 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 11706924 | Commonly used antibacterial and antifungal agents for hospitalised paediatric patients: implications for therapy with an emphasis on clinical pharmacokinetics. | Paediatr Drugs | 2001 | https://conductscience.org/library/papers/11706924 | PubMed |
| 8181493 | New perspectives in understanding and management of the respiratory disease in cystic fibrosis. | Eur J Pediatr | 1994 | https://conductscience.org/library/papers/8181493 | PubMed |
| 8067743 | Pulmonary retention of free and liposome-encapsulated tobramycin after intratracheal administration in uninfected rats and rats infected with Pseudomonas aeruginosa. | Antimicrob Agents Chemother | 1994 | https://conductscience.org/library/papers/8067743 | PubMed |
| 7649191 | Correlation between activity of beta-lactam agents in vitro and bacteriological outcome in acute pulmonary exacerbations of cystic fibrosis. | Eur J Clin Microbiol Infect Dis | 1995 | https://conductscience.org/library/papers/7649191 | PubMed |
| 7094939 | Sputum penetration of fusidic acid in patients with cystic fibrosis. | Eur J Pediatr | 1982 | https://conductscience.org/library/papers/7094939 | PubMed |
| 6981383 | Pseudomonas infection, allergy, and cystic fibrosis. | Arch Dis Child | 1982 | https://conductscience.org/library/papers/6981383 | PubMed |
| 6810763 | Circulating soluble immune complexes containing pseudomonas antigens in cystic fibrosis. | Arch Dis Child | 1982 | https://conductscience.org/library/papers/6810763 | PubMed |
| 6756730 | Functional activity of peripheral mononuclear cells in cystic fibrosis: antibodies and plaque formation. | Clin Exp Immunol | 1982 | https://conductscience.org/library/papers/6756730 | PubMed |
| 6732230 | Azlocillin pharmacokinetics in patients with cystic fibrosis. | Antimicrob Agents Chemother | 1984 | https://conductscience.org/library/papers/6732230 | PubMed |
| 6426075 | Azlocillin compared with carbenicillin in the treatment of bronchopulmonary infection due to Pseudomonas aeruginosa in cystic fibrosis. | Thorax | 1984 | https://conductscience.org/library/papers/6426075 | PubMed |
| 4083865 | Pharmacokinetics and dosage requirements of netilmicin in cystic fibrosis patients. | Antimicrob Agents Chemother | 1985 | https://conductscience.org/library/papers/4083865 | PubMed |
| 3859245 | Pharmacokinetics of imipenem and cilastatin in patients with cystic fibrosis. | Antimicrob Agents Chemother | 1985 | https://conductscience.org/library/papers/3859245 | PubMed |
| 3780832 | Pharmacokinetics of amikacin in cystic fibrosis: a study of bronchial diffusion. | Eur J Clin Pharmacol | 1986 | https://conductscience.org/library/papers/3780832 | PubMed |
| 3522911 | Viral infection in cystic fibrosis. | J R Soc Med | 1986 | https://conductscience.org/library/papers/3522911 | PubMed |
| 3497170 | Prevalence of thymidine-dependent Staphylococcus aureus in patients with cystic fibrosis. | J Clin Microbiol | 1987 | https://conductscience.org/library/papers/3497170 | PubMed |
| 3311531 | Antibiotic pharmacokinetics in cystic fibrosis. Differences and clinical significance. | Clin Pharmacokinet | 1987 | https://conductscience.org/library/papers/3311531 | PubMed |
| 3118820 | Prospective study of serum staphylococcal antibodies in cystic fibrosis. | Arch Dis Child | 1987 | https://conductscience.org/library/papers/3118820 | PubMed |
| 3117842 | Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis. | J Clin Microbiol | 1987 | https://conductscience.org/library/papers/3117842 | PubMed |
| 3115896 | Role of sialic acid in saliva-mediated aggregation of Pseudomonas aeruginosa isolated from cystic fibrosis patients. | Infect Immun | 1987 | https://conductscience.org/library/papers/3115896 | PubMed |
| 3093524 | Variation and adaptation of Pseudomonas aeruginosa toxicity to HeLa cells and fibroblasts. | J Clin Microbiol | 1986 | https://conductscience.org/library/papers/3093524 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7007597
GET https://conductscience.org/api/papers/v1/7007597/cited_by?page=2